LAG3 Antikörper (C-Term)

Produktnummer ABIN929141

Der Kaninchen Polyklonal anti-LAG3 Antikörper wird verwendet zum Nachweis von LAG3 in Proben von Human. Er wurde validiert für WB.

Kurzübersicht für LAG3 Antikörper (C-Term) (ABIN929141)

Target: LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LAG3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-LAG3 Antikörper

Bindungsspezifität: C-Term

Aufreinigung: Purified

Immunogen: LAG3 antibody was raised in rabbit using the C terminal of LAG3 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

LAG3 Blocking Peptide, (ABIN938646), is also available for use as a blocking control in assays to test for specificity of this LAG3 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu LAG3

Target: LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Andere Bezeichnung: LAG3

Hintergrund: Lymphocyte-activation protein 3 belongs to Ig superfamily and contains 4 extracellular Ig-like domains. The LAG3 gene contains 8 exons. The sequence data, exon/intron organization, and chromosomal localization all indicate a close relationship of LAG3 to CD4. Synonyms: Polyclonal LAG3 antibody, Anti-LAG3 antibody, lymphocyte-activation gene 3 antibody, CD223 antibody.

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints